Cetuximab plus platinum-based chemotherapy in head and neck squamous cell carcinoma: a randomized, double-blind safety study comparing cetuximab produced from two manufacturing processes using the EXTREME study regimen
about
Cetuximab plus platinum-based chemotherapy in head and neck squamous cell carcinoma: a randomized, double-blind safety study comparing cetuximab produced from two manufacturing processes using the EXTREME study regimen
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Cetuximab plus platinum-based ...... sing the EXTREME study regimen
@ast
Cetuximab plus platinum-based ...... sing the EXTREME study regimen
@en
type
label
Cetuximab plus platinum-based ...... sing the EXTREME study regimen
@ast
Cetuximab plus platinum-based ...... sing the EXTREME study regimen
@en
prefLabel
Cetuximab plus platinum-based ...... sing the EXTREME study regimen
@ast
Cetuximab plus platinum-based ...... sing the EXTREME study regimen
@en
P2093
P2860
P1433
P1476
Cetuximab plus platinum-based ...... sing the EXTREME study regimen
@en
P2093
Coleman K Obasaju
Denis Soulières
Douglas Adkins
Hyun Jung Lee
Jose Luis Aguilar
Katherine Bryant
Krzysztof Misiukiewicz
Scott Ernst
Shao-Chun Chang
P2860
P2888
P356
10.1186/S12885-016-2064-0
P407
P577
2016-01-14T00:00:00Z
P5875
P6179
1047732200